The levels of HbA1c in patients with thyroid dysfunction
Tiroid disfonksiyonlu hastalarda HbA1c düzeyleri
Abstract views: 327 / PDF downloads: 83
DOI:
https://doi.org/10.5455/GMJ-30-161185Keywords:
Thyroid dysfunction, HbA1c, Insulin resistanceAbstract
Thyroid hormones increase the hepatic glyconeogenesis, glycogenolysis and the absorption of glucose. Glucose intolerance is common in thyroid dysfunction. HbA1c is the most important determinant of long term glysemic status in diabetic patients. HbA1c is affected from various factors. In this study we evaluated the relation between thyroid function tests and HbA1c in non-diabetic patients with thyroid dysfunction. Non-diabetic 43 patients with hyperthyroidism, 20 patients with hypothyroidism and for control group 29 euthyroid patients which appealed to Ankara Numune Training and Research Hospital Internal Outpatient Clinic between June 2008 and January 2009 were recruited to this study. Fasting blood sugar, urea, creatinine, hemoglobine, HbA1c, TSH, FT3, FT4 and albumine levels of all of the patients that recruited to study were determined. There was no statistically significant difference for the mean age (p=0.271) and gender distribution (p=0.23) in the cases of hyperthyroidism, hypothyroidism and euthyroid controls. HbA1c levels were significantly higher in hyperthyroid group when compared to hypothyroid and euthyroid groups (p<0,001). Fasting blood glucose levels were found significantly higher in hyper thyroid group than hypothyroid and euthyroid groups (p=0.018). A positive correlation was revealed between the increasing age and HbA1c levels. A statistically significant difference was found in the levels of HbA1c values in patients with hyperthyroidism according to euthyroid and hypothyroid patients and this finding is in compliance with the results of current literature. This makes us to think that here is a relation between insulin resistance and hyperthyroidism. Therefore, it is suggested that monitorisation of blood glucose levels regularly is useful for the early diagnose of type II diabetes mellitus in patients with hyperthyroidism, both during the therapy and post treatment period.
Metrics
References
Koloğlu S, Erdoğan G. Genel Görüş ve Bilgiler. Koloğlu Endokrinoloji Temel ve Klinik. MN Medikal & Nobel.2.Baskı.2003.155-172.
WJ Hueston. Treatment of hypothyroidism. Am FamPhysician 2001;64:1717-24.
Sayinalp S. Tiroid Hastalıklarina Giriş.İç Hastalıkları. Güneş Kitabevi. 2. Baskı, 2003:2167-2174
Roubsanthisuk W, Watanakejorn P, Tunlakit M, Sriussadaporn S. Hyperthyroidism induces glucose intolerance by lowering bothinsulin secretion and peripheral insülin sensitivity. J Med Assoc Thai 2006 ;89 :s133-40.
Gasinska T, Wawrzyniak L. Glucose tolerance and insülin secretion in patients with hyperthyroidism. Pathogenesis of disturbances and therapeutic consequences. Pol Tyg Lek.1994 ;49:43-5.
Nambiar S, Zachariah B, Magadi G.S. İncreased glycation of hemoglobin in chronic renal failure patients and its potential role of oxidative stress. Archives of Medical Research 2008;39: 277-284.
Weykamp C, Garry J.W, Andrea M, Tadao H, RandieL, Jan-Olof J, ET AL.The IFCC reference measuremen tsystem for HbA1c:A 6 year progress report. Clin Chem.2008 ;54(2): 240-8.
David S.C, Francis S, Paul W. Tiroid Bezi. Greenspan’s Temel ve Klinik Endokrinoloji. Güneş Tıp Kitapevleri. 8.Baskı. 2009:227-229.
Roubsanthisuk W, Watanakejorn P, Tunlakit M, Sriussadaporn S. Hyperthyroidism induces glucose intolerance by lowering both insülin secretion and peripheral insulin sensitivity. JMedAssoc Thai.2006;89:s133-40.
Liang Z, Luo GC, Hu QH, Li MZ, Chen N, Yan DW, et al. Evaluation of insulin secretion and insulin resistance by hyperglycemic clamp in Graves disease patients with impared glucose tolerance. Zhonghua Nei Ke Za Zhi 2007; 46(7): 559-61.
Dimitradis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E,et al. Insulin stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. JClin Endocrinol Metab.2008 ;93(6):2413-5.
Paul DT, Mollah FH, Alam MK, Fariduddin M, Azad K, ArslanMI. Glycemic status in hyperthyroid subjects. Mymensingh Med J 2004;13(1):71-5.
Pavliuk PM. Disordered glucose tolerance in diffuse toxic goiter. Probl Endokrinol(Mosk)1990;36(2): 17-21.
Aheemstra KJ, SmitWA, Aeustatia CF, Heijboer AC, Frölicht M, RomjinJ A. Glucose tolerance and lipid profile in long term exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlledtrial. Clinical Endocrinology 2006; 65:737-744.
Satoshi O, Kazumi N, YuzuruK. Correlation of plasma free Thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid graves’ disease. Intern Med 1995;34(5):339-341.
Dimitriadis G, Maratou E, Alevizaki M, Boutati E, Psara K, Papasteriades C, et al. Thyroid hormone excess increases basal and insulin stimulated recruitment of GLUT3 glucose transporters on cellsurface. Horm Metab Res 2005; 37(1):15-20.
Mohan KM, Bobby Z, Selvaraj N et al. Possible link between glycated hemoglobin and lipid peroxidation in hyperthyroidism. Clinica Chimica Acta 2004;342: 187-192.
Ford HC, Lim WC, Crooke MJ. Hemoglobin A1 and serum fructosamine levels in hyperthyrodism. Clin Chim Acta.1987;166:317-21.
Kim MK, Kwon HS, Baek KH, Lee JH, Park WC, Sohn HS, et al. Effects of thyroid hormone on A1C and glycated albumin levels in nondiabetic subjects with over thypothyroidism. Diabetes Care 2010; 33(12):2546-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.